Literature DB >> 8726177

Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer.

N Baxter1, D McCready, J A Chapman, E Fish, H Kahn, W Hanna, M Trudeau, H L Lickley.   

Abstract

BACKGROUND: The purpose of this study was to examine the rate of axillary failure in patients with primary breast cancer treated without axillary dissection or radiation and to determine what factors may be associated with axillary failure.
METHODS: We studied 112 patients with invasive breast cancer treated for primary disease with breast-conserving surgery without axillary dissection or radiation to the breast or axilla, accrued between 1977 and 1986. Data for these patients were prospectively gathered for a research database and reviewed retrospectively to determine axillary failure. The effects of age, tumor size, estrogen receptor (ER) status, progesterone receptor (PgR) status, histologic grade, nuclear grade, and tumor emboli on time to axillary failure were examined.
RESULTS: The median follow-up was 9.6 years. There were 26 axillary recurrences, resulting in a 10-year actuarial nodal control rate of 72%. Patients with nodal failure proceeded to axillary dissection with minimal morbidity. In both univariate and multivariate analyses, only tumor size was significantly associated with axillary failure (p = 0.04 and p = 0.06, respectively).
CONCLUSIONS: This study demonstrates a significant effect of tumor size on axillary failure and a reasonable rate of local control in small tumors. Further research should examine the utility of axillary dissection in women with small breast cancers.

Entities:  

Mesh:

Year:  1996        PMID: 8726177     DOI: 10.1007/BF02306277

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  25 in total

1.  Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates.

Authors:  M Hladiuk; S Huchcroft; W Temple; B E Schnurr
Journal:  J Surg Oncol       Date:  1992-05       Impact factor: 3.454

2.  Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.

Authors:  B G Mobbs; I E Johnson
Journal:  J Steroid Biochem       Date:  1987-12       Impact factor: 4.292

3.  The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women.

Authors:  H B Muss
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

Review 4.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

5.  New therapeutic possibilities in primary invasive breast cancer.

Authors:  B Cady; M D Stone; J Wayne
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

6.  Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings.

Authors:  R A Sacre
Journal:  Eur J Surg Oncol       Date:  1986-06       Impact factor: 4.424

7.  Recent incidence trends for breast cancer in women and the relevance of early detection: an update.

Authors:  B A Miller; E J Feuer; B F Hankey
Journal:  CA Cancer J Clin       Date:  1993 Jan-Feb       Impact factor: 508.702

8.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

Authors:  B Fisher; C Redmond; E R Fisher; M Bauer; N Wolmark; D L Wickerham; M Deutsch; E Montague; R Margolese; R Foster
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

9.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

Authors:  B Fisher; M Bauer; R Margolese; R Poisson; Y Pilch; C Redmond; E Fisher; N Wolmark; M Deutsch; E Montague
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

10.  Surgery in the primary treatment of breast cancer.

Authors:  N Wolmark; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

View more
  6 in total

1.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast.

Authors:  D F Roses; A D Brooks; M N Harris; R L Shapiro; J Mitnick
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  [Axillar lymphadenectomy].

Authors:  D Oertli
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

3.  Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis.

Authors:  M Greco; R Agresti; N Cascinelli; P Casalini; R Giovanazzi; A Maucione; G Tomasic; C Ferraris; M Ammatuna; S Pilotti; S Menard
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

4.  Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer.

Authors:  Mehmet Keskek; Sener Balas; Aytac Gokoz; Iskender Sayek
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

5.  Sentinel lymph node biopsy in breast cancer.

Authors:  Abdulaziz A Alsaif
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484

6.  Axillary Recurrence in Breast Cancer Patients After Negative Sentinel Lymph Node Biopsy: Retrospective Cohort Study From Riyadh, Saudi Arabia.

Authors:  Roqayah I Alsunitan; Abdulaziz Al-Saif; Bader A Alyousef; Saud M Alghamdi; Shaimaa A Bugshan
Journal:  Cureus       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.